You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TOR Serine-Threonine Kinases

Showing 1 - 25 of 360
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension Trial in Lancaster (Salt loading, Hydrochlorothiazide (HCTZ))

Completed
Has Results
  • Hypertension
  • Salt loading
  • Hydrochlorothiazide (HCTZ)
  • Lancaster, Pennsylvania
    Amish Research Clinics
Mar 23, 2022

Cancer (With or Without Metastasis) Trial in Houston (TSN084)

Recruiting
  • Cancer (With or Without Metastasis)
  • Houston, Texas
    MD Anderson Cancer Center
Apr 22, 2022

BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)

Recruiting
  • BRAF V600E
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +33 more
Dec 20, 2022

Interstitial Fibrosis, Kidney Transplant; Complications, Kidney Transplant Rejection Trial in Houston (Fingolimod, Placebo)

Enrolling by invitation
  • Interstitial Fibrosis
  • +6 more
  • Houston, Texas
    Houston Methodist Research Institute
Jan 23, 2023

NSCLC Trial in China (JAB 21822)

Recruiting
  • Non-small Cell Lung Cancer
  • JAB 21822
  • Beijing, Beijing, China
  • +20 more
Sep 26, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma Trial in United States

Active, not recruiting
  • Stage III Cutaneous Melanoma AJCC v7
  • +2 more
  • Computed Tomography
  • +3 more
  • Birmingham, Alabama
  • +759 more
Aug 18, 2022

NSCLC Trial in Worldwide (Sotorasib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Birmingham, Alabama
  • +65 more
Nov 29, 2022

Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)

Active, not recruiting
  • Low-grade Glioma
  • +2 more
  • Calgary, Alberta, Canada
  • +6 more
Oct 25, 2022

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Advanced Solid Tumors Trial in United States (TP-0184)

Completed
  • Advanced Solid Tumors
  • Scottsdale, Arizona
  • +4 more
Apr 4, 2022

NSCLC Trial (Bemcentinib, Pembrolizumab, Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Jul 19, 2022

Real-World Evidence In Patients Treated With Palbociclib

Recruiting
  • Metastatic Breast Cancer
  • Timisoara, Timiș, Romania
  • +5 more
Dec 7, 2022

Out-Of-Hospital Cardiac Arrest Trial in Taipei (termination of resuscitation rules)

Recruiting
  • Out-Of-Hospital Cardiac Arrest
  • termination of resuscitation rules
  • Taipei, Taiwan
    National Taiwan University
Sep 19, 2022

Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Foshan, Guangdong, China
  • +8 more
Mar 28, 2022

BRAF V600E Unresectable or Metastatic Melanoma, BRAF V600E Metastatic NSCLC, Melanoma Trial in Guangzhou (Encorafenib)

Completed
  • BRAF V600E Unresectable or Metastatic Melanoma
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 9, 2022

Healthy Trial in Toronto (Dietary Intakes)

Completed
  • Healthy
  • Dietary Intakes
  • Toronto, Ontario, Canada
    The Hospital for Sick Children
Oct 24, 2022

Crohn Disease Trial in Ann Arbor (Low serine diet, High serine diet)

Recruiting
  • Crohn Disease
  • Low serine diet
  • High serine diet
  • Ann Arbor, Michigan
    University of Michigan
May 19, 2022

Hereditary Sensory Neuropathy Type I Trial in London (L-serine, Placebo)

Recruiting
  • Hereditary Sensory Neuropathy Type I
  • London, United Kingdom
    University College London
Oct 31, 2023

Acute Orthopedic Injury Trial in Boston (Toolkit for Optimal Recovery after Orthopedic Injury, Minimally Enhanced Usual Care

Recruiting
  • Acute Orthopedic Injury
  • Toolkit for Optimal Recovery after Orthopedic Injury
  • Minimally Enhanced Usual Care (MEUC)
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 23, 2022

Toxicity, Healthy Trial in Melbourne (GFH312, Placebo)

Recruiting
  • Toxicity
  • Healthy
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Jan 18, 2022

Healthy Volunteers Trial in Rennes (ANT3310, ANT3310-, Meropenem)

Recruiting
  • Healthy Volunteers
  • Rennes, France
    Biotrial
Jun 13, 2023

Breast Cancer Trial (GSK3326595)

Completed
  • Breast Cancer
  • London, Ontario, Canada
    St. Joseph's Health Care London
Oct 24, 2022

MDD Trial in Basel (D-serine, Placebo)

Recruiting
  • Major Depressive Disorder
  • D-serine
  • Placebo
  • Basel, Baselstadt, Switzerland
    University of Basel, Department of Psychiatry (UPK)
Oct 31, 2022

imPulse™ Tor System Self-Directed Cuffless Blood Pressure

Completed
  • AI-driven, Self-directed Blood Pressure Monitoring
  • imPulse™ Tor System
  • Sacramento, California
    UCD Sports Medicine
Sep 11, 2022

Dysphagia, Stroke Trial in Toronto (TOR-BSST© eLearning Training, Standard TOR-BSST© Training)

Recruiting
  • Dysphagia
  • Stroke
  • TOR-BSST© eLearning Training
  • Standard TOR-BSST© Training
  • Toronto, Ontario, Canada
    University Health Network
May 12, 2022